 |
Autologous Epstein-Barr virus specific T-cells derived from peripheral blood mononuclear cells, expanded ex vivo |
|---|---|
| Trade Name | |
| Orphan Indication | Post-transplant lymphoproliferative disorder |
| EU Market Approval | EU |
| EU Designation Date | 2016-07-14 00:00:00 |
| Sponsor | Cell Medica Ltd. |
